Estimated prices of agents approved to treat prostate cancer
Treatment | Cost of treatment alonea | Median overall survival benefit |
---|---|---|
sipuleucel-T | $93,000 (median 3 cycles) | 25.8 months vs. 21.7 months [9] |
enzalutamide | $89,952 (median of 8 cycles) | 18.4 months vs. 13.6 months [4] |
abiraterone | $144,950 (median of 14 cycles) | 34.7 vs. 30.3 months [6, 59] |
docetaxel | $25,000 (median of 10 cycles) | 18.9 months vs. 16.5 months [60] |
cabazitaxel | $68,751 (median of 6 cycles) | 15.1 months vs. 12.7 months [7] |
radium-223 | $155,048 (median of 6 injections) | 14.9 months vs. 11.3 months [8] |
aAs determined by using estimates of average wholesale drug prices retrieved from UptoDate accessed 11/17/2016